Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02992795 · ClinicalTrials.gov registry record
Unblinded Data Collection Study of Concussion Using BrainPulse
A clinical trial of Concussion, Intermediate, sponsored by Jan Medical.
- Completed
- Registry status
- 353
- Enrollment target
- 1
- Study location
NCT02992795 is a study of Concussion, Intermediate that has completed, run by Jan Medical. The registered enrollment target is 353 participants, above the 198-participant average among 5 other Concussion, Intermediate trials with a reported enrollment target (78% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02992795, a study of Concussion, Intermediate, has completed, sponsored by Jan Medical.
- COMPLETED
- Registry status
- 353 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, non-blinded, matched control study of young athletes (ages 10-28 years old) in collegiate sports. The cohorts are defined in accordance to the athlete's exposure of injury. All subjects will complete a minimum of one recording based on their assigned cohort. Concussed athletes will complete an additional 3 weeks of follow-up recordings post injury. The symptomatic evaluation, physical examination, neurological baseline testing, and BrainPulse recordings will be entered in a database to determine clinical outcome and assess device utilization.
Conditions Studied
Interventions
- DEVICE BrainPulse
Study Locations (1)
Wyoming
- University of Wyoming - Laramie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 353 participants |
| Start Date | 2016-11 |
| Est. Completion | 2017-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02992795
The ClinicalTrials.gov registry entry for NCT02992795 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 353 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 198-participant average among 5 other Concussion, Intermediate trials with a reported enrollment target (78% higher). The listed sponsor is Jan Medical, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Concussion, Intermediate appearing as the primary indexed condition, and to 1 intervention - of which BrainPulse is the first listed.
NCT02992795 reports 1 study location spanning 1 distinct geographic area - top geographies include Wyoming.
Frequently Asked Questions
What is clinical trial NCT02992795 about?
NCT02992795 is a clinical study titled "Unblinded Data Collection Study of Concussion Using BrainPulse". This is a prospective, non-blinded, matched control study of young athletes (ages 10-28 years old) in collegiate sports. The cohorts are defined in accordance to the athlete's exposure of injury. All subjects will complete a minimum of one recording based on their assigned cohort. Concussed athletes...
What is the current status of trial NCT02992795?
This trial is currently completed. The enrollment target is 353 participants. The study started on 2016-11. Estimated completion is 2017-08.
What conditions does trial NCT02992795 study?
This clinical trial studies the following conditions: Concussion, Intermediate.
What interventions are being tested in trial NCT02992795?
The interventions under investigation include: BrainPulse (DEVICE).
Who is sponsoring clinical trial NCT02992795?
This trial is sponsored by Jan Medical, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02992795 being conducted?
This trial has 1 study location across Wyoming. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Concussion, Intermediate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Magnesium and Riboflavin Treatment for Post-Concussion Headache
RECRUITING · Phase 2
-
Facilitating Access to Specialty Treatment
RECRUITING · NA
-
Intervention to Change Affect Recognition and Empathy
ACTIVE NOT RECRUITING · NA
-
Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients
COMPLETED
-
Objective Brain Function Assessment of mTBI/Concussion
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.